A detailed history of Warberg Asset Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Warberg Asset Management LLC holds 3,500 shares of MRNA stock, worth $128,975. This represents 1.85% of its overall portfolio holdings.

Number of Shares
3,500
Holding current value
$128,975
% of portfolio
1.85%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$63.64 - $125.14 $222,740 - $437,990
3,500 New
3,500 $233,000
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $289,230 - $379,830
3,000 New
3,000 $309,000
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $338,955 - $553,133
1,501 New
1,501 $381,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Warberg Asset Management LLC Portfolio

Follow Warberg Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warberg Asset Management LLC with notifications on news.